Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis
The skin-based test can be used on children as young as two days old
The skin-based test can be used on children as young as two days old
In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning
From - Diagnostic Testing & Emerging Technologies
The notion of empowering patients to take control over their own health care is particularly powerful within the realm of…
Genetic testing laboratories should ask a series of questions prior to billing for these assays
From - Diagnostic Testing & Emerging Technologies
The National Comprehensive Cancer Network genetic testing criteria for hereditary cancer miss almost one in five at-risk for…